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  2. MATERIAL AND METHODS     
  Subjects and assays 
 To perform this study we recruited 81 young adults (62 females and 19 males aged 20,2 ±1,7 
years). All volunteers gave their written informed consent. Standardized interviewer-
administered questionnaire was performed in all subjects, which included questions about 
smoking habits, oral contraceptive therapy, caloric intake, fasting time, and physical activity. 
Exclusion criteria included the presence of liver and/or hematological disorders.  
  For each individual, after an overnight fasting, venous blood samples were collected in 
order to determine total and direct-reacting bilirubin. Genomic DNA was isolated for molecular 
study of UGT1A1 gene promoter, followed PCR amplification as previously described5.  
   
  Data Analysis 
 For statistical analysis, the Statistical Package for Social Sciences, version 16.0 was used. 
Kolmogorov Smirnov statistics were used to assess sample normality distribution. Multiple 
comparisons between groups were performed by one-way ANOVA supplemented with Tukey’s 
HSD post-hoc test. Spearman correlation coefficient was used to evaluate relationships between 
sets of data. Logistic regression analysis and adjusted general linear regression model was 
used to estimate the proportion of the variation of bilirubin concentration explained by different 
variables. Significance was accepted at p<0.05. Hardy-Weinberg equilibrium was evaluated with 
the software available at http://www.changbioscience.com/genetics/hardy.html/.  
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1. INTRODUCTION 
 
   UDP-glucuronosyltransferase 1A1 (UGT1A1) gene is considered a major 
determinant in serum bilirubin levels1. Patients with Gilbert’s syndrome (GS) 
are often homozygous for a TA insertion in the TATA-box region of the 
UGT1A1 gene.  The presence of this TA7 allele decreases UGT1A1 
transcription, and therefore, reduces glucuronidation, resulting in increased 
unconjugated bilirubin serum levels.  
  It is well established that other non-genetic factors like gender2, age3, or 
smoking status4, influence the inter-individual variation of bilirubin levels. 
However, there are few studies that relate the influence of genetic and non 
genetic variables in serum bilirubin concentration.  
  To clarify this issue, our aim was to determine the influence of the TA 
polymorphism and other non-genetic factors that could contribute to the 
bilirubin variation in Portuguese population. 
 4. DISCUSSION 
        
  Our study showed:  
- A clear association between the TA repeat polymorphism and bilirubin concentration. Multiple comparison analysis demonstrated that significant 
statistical differences occur within genotype 6/6 and 6/7 (p=0.008) and is more pronounced between 6/6 and 7/7 genotype (p=0.004). 
 
- Higher serum bilirubin levels in males. 
 
- No statically significant differences were found in smoking status, oral contraceptive therapy and physical activity.  
 
- Statistically significant correlations were found between bilirubin serum level and fasting time and caloric intake. 
  
- Regression analysis strongly suggest that genetic background plays a major role in serum bilirubin levels variation (23%), in this population.   
- Moreover, gender, caloric intake, fasting time, could also contribute to the inter-individual variation.  
  
 In conclusion, the establishment of factors that might contribute to the observed inter-individual differences will be crucial for many clinical conditions 
which diagnosis, prognosis and treatment are associated with bilirubin levels. 
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3. RESULTS 
 
 
 
 
 
 
 
 
 
Fig.1 - Differences 
between: smokers 
and no-smokers (A); 
genotypes 6/6, 6/7 
and 7/7 (B); women 
under contraceptive 
therapy and without 
contraceptive 
therapy (C); gender 
(D). Correlations 
between total serum 
bilirubin levels 
(µmol/L) and: 
caloric intake (E); 
fasting time (F). 
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